News Focus
News Focus
icon url

Beandog

12/09/14 6:06 PM

#57178 RE: biotech_researcher #57172

All the other biotechs that hit their stride compound after compound, and this one [Ariad] delivers failure after failure..



Failure after failure... And you are still long? A bit unorthodox investment strategy but to each his own I suppose.
icon url

AmpleKind

12/10/14 12:44 PM

#57202 RE: biotech_researcher #57172

No way $20. Molecule N will help, but it will have the Ariad discount, which may give us $2 no matter how glowing the possibilities.


Preposterous on the face of it! Let's not confuse attitude with opinion.

All the other biotechs that hit their stride compound after compound


Simply false, Many, if not most biotechs fail before they ever deliver
their first product. Aria produced two of the most efficacious drugs in
their respective arena (which btw is expanding) and own a discovery
platform that produced them, and more to come.

this one delivers failure after failure..


Read previous points.

Thanks for the ... ahem.... "skeptical" point of view.